We are live on ! Find out more
GAMA

Graticule Asia Macro Advisors Portfolio holdings

AUM $649M
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.72B
AUM Growth
+$889M
Cap. Flow
+$832M
Cap. Flow %
48.44%
Top 10 Hldgs %
45.01%
Holding
174
New
76
Increased
21
Reduced
13
Closed
54

Sector Composition

Rank Sector Weight
1 Communication Services 12.41%
2 Technology 10.3%
3 Healthcare 6.35%
4 Consumer Discretionary 5.59%
5 Financials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DO
101
DELISTED
Diamond Offshore Drilling
DO
$1.92M 0.11%
+115,000
New +$1.95M
AVXS
102
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.74M 0.1%
22,845
-4,050
-15% -$251K
PBYI icon
103
Puma Biotechnology
PBYI
$404M
$1.73M 0.1%
46,410
+21,410
+86% +$781K
CALA
104
DELISTED
Calithera Biosciences, Inc
CALA
$1.13M 0.07%
+4,878
New +$843K
EDIT icon
105
Editas Medicine
EDIT
$396M
$1.12M 0.07%
+50,000
New +$1.04M
WBA
106
DELISTED
Walgreens Boots Alliance
WBA
$997K 0.06%
12,000
RGNX icon
107
Regenxbio
RGNX
$620M
$949K 0.06%
49,150
HQY icon
108
HealthEquity
HQY
$8.41B
$934K 0.05%
+22,000
New +$974K
ALNY icon
109
Alnylam Pharmaceuticals
ALNY
$27.5B
$923K 0.05%
+18,018
New +$833K
JUNO
110
DELISTED
Juno Therapeutics, Inc.
JUNO
$909K 0.05%
40,950
+20,700
+102% +$444K
AKAO
111
DELISTED
Achaogen Inc
AKAO
$878K 0.05%
34,800
-40,200
-54% -$826K
SGYP
112
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$641K 0.04%
+137,600
New +$798K
VWO icon
113
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$600K 0.03%
+15,115
New +$583K
EEM icon
114
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$424K 0.02%
+10,763
New +$409K
PTGX icon
115
Protagonist Therapeutics
PTGX
$8.79B
$408K 0.02%
31,827
AERI
116
DELISTED
Aerie Pharmaceuticals
AERI
$400K 0.02%
8,820
-18,580
-68% -$829K
SRPT icon
117
Sarepta Therapeutics
SRPT
$1.57B
$306K 0.02%
10,350
BABA icon
118
Alibaba
BABA
$293B
$295K 0.02%
+2,739
New +$279K
NSTG
119
DELISTED
NanoString Technologies, Inc.
NSTG
$238K 0.01%
12,000
RCKT icon
120
Rocket Pharmaceuticals
RCKT
$340M
$32K ﹤0.01%
4,054
AAPL icon
121
PUT
Apple
AAPL
$4.54T
-1,800,000
Closed -$52.1M
ACAD icon
122
Acadia Pharmaceuticals
ACAD
$4.43B
-14,000
Closed -$404K
AEO icon
123
PUT
American Eagle Outfitters
AEO
$2.88B
-300,000
Closed -$4.55M
AGIO icon
124
CALL
Agios Pharmaceuticals
AGIO
$1.79B
-12,500
Closed -$522K
ALB icon
125
Albemarle
ALB
$13.9B
-93,000
Closed -$8.01M

Similar funds

Graticule Asia Macro Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Graticule Asia Macro Advisors held 174 positions worth $1.72B, up 107% from $829M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Graticule Asia Macro Advisors deployed $832M of net new capital in Q1 2017, opening 76 new positions and adding to 21 existing holdings. Its largest new stake was Block Inc: 2,824,039 shares worth $48.8M.

By sector, the portfolio is most concentrated in Communication Services at 12% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $14.2M trimmed.

  • Graticule Asia Macro Advisors's largest Q1 2017 buy was Block Inc: 2,824,039 shares worth $48.8M.
  • Graticule Asia Macro Advisors added most to Alphabet (Google) Class A in Q1 2017, an estimated $40.5M increase.
  • Graticule Asia Macro Advisors's biggest Q1 2017 reduction was Microsoft, cutting an estimated $14.2M.
  • Graticule Asia Macro Advisors fully exited iShares US Home Construction ETF in Q1 2017, selling an estimated $15.9M.
  • Graticule Asia Macro Advisors's ten largest holdings make up 45% of its $1.72B portfolio in Q1 2017.
  • Graticule Asia Macro Advisors opened 76 new positions and closed 54 in Q1 2017.
  • Graticule Asia Macro Advisors's portfolio value rose 107% quarter-over-quarter to $1.72B.

Based on Graticule Asia Macro Advisors's 13F filing for Q1 2017, filed 12 May 2017.